Unusual Distribution of Mutations Associated with Serial Bottleneck Passages of Human Immunodeficiency Virus Type 1

Size: px
Start display at page:

Download "Unusual Distribution of Mutations Associated with Serial Bottleneck Passages of Human Immunodeficiency Virus Type 1"

Transcription

1 JOURNAL OF VIROLOGY, Oct. 2000, p Vol. 74, No X/00/$ Copyright 2000, American Society for Microbiology. All Rights Reserved. Unusual Distribution of Mutations Associated with Serial Bottleneck Passages of Human Immunodeficiency Virus Type 1 ELOISA YUSTE, 1 CECILIO LÓPEZ-GALÍNDEZ, 2 AND ESTEBAN DOMINGO 1 * Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Cantoblanco, Madrid, 1 and Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Majadahonda, Madrid, 2 Spain Received 8 May 2000/Accepted 18 July 2000 Repeated bottleneck passages result in fitness losses of RNA viruses. In the case of human immunodeficiency virus type 1 (HIV-1), decreases in fitness after a limited number of plaque-to-plaque transfers in MT-4 cells were very drastic. Here we report an analysis of entire genomic nucleotide sequences of four HIV-1 clones derived from the same HIV-1 isolate and their low-fitness progeny following 7 to 15 plaque-to-plaque passages. Clones accumulated 4 to 28 mutations per genome, with dominance of A G and G A transitions (57% of all mutations) and 49% nonsynonymous replacements. One clone but not three sibling clones showed an overabundance of G A transitions, evidencing the highly stochastic nature of some types of mutational bias. The distribution of mutations along the genome was very unusual in that mutation frequencies in gag were threefold higher than in env. Particularly striking was the complete absence of replacements in the V3 loop of gp120, confirmed with partial nucleotide sequences of additional HIV-1 clones subjected to repeated bottleneck passages. The analyses revealed several amino acid replacements that have not been previously recorded among natural HIV-1 isolates and illustrate how evolution of an RNA virus genome, with regard to constant and variable regions, can be profoundly modified by alterations in population dynamics. Retroviruses and in particular human immunodeficiency virus type 1 (HIV-1) mutate and recombine at high rates (14, 15, 39, 55, 60, 61, 70, 74). Rapid genetic variation, together with the short replication times of HIV-1 (8), generates complex and highly dynamic mutant swarms termed viral quasispecies (10, 18 22, 42, 66, 69). The mutant spectra of viral quasispecies constitute reservoirs of phenotypically relevant variants, as evidenced by the nonsyncytial-to-syncytial switch in infected individuals or the rapid selection of antibody-, cytotoxic-t-cell-, or inhibitor-resistant mutants in viral populations in vivo (2 4, 32, 33, 36, 37, 41, 46, 47, 56, 59, 65). Although most individual mutations in mutant swarms of RNA viruses may not be of immediate or even long-term selective value for the virus (63), evolution of viral quasispecies can be adaptive and may exert an influence in viral pathogenesis (26, 34, 76; reviews in 10, 28, 29). The adaptive potential of viral quasispecies is manifested by quantitatively important fitness variations as viruses evolve in constant or changing environments (for recent examples and reviews, see 10, 11, 13, 31, 48, 50 52, 75). Large-population passages under a constant environment tend to produce fitness gains in viral populations (10, 11, 13, 25, 51, 52). In contrast, bottleneck events experimentally realized in an extreme case by serial plaque-to-plaque transfers of virus on cell monolayers often lead either to average fitness losses (6, 17, 24, 78) or to limitations of fitness gains (23, 51, 52). The decrease in fitness mediated by repeated bottlenecks has been interpreted as the result of an accentuation of Muller s ratchet effect (45). According to this model, asexual populations of organisms with a small population size will tend to incorporate deleterious mutations unless compensatory mechanisms such as recombination can restore mutation-free genomes (45). For RNA virus quasispecies, accumulation of * Corresponding author. Mailing address: Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain. Phone: Fax: edomingo@cbm.uam.es. deleterious mutations is expected from successive rounds of random sampling of genomes from the mutant spectrum (reviewed in 10, 11). In retroviruses, decreases in fitness as a result of serial bottleneck passages were first documented with HIV-1 following plaque-to-plaque passages on MT-4 cells (78). In this virus, fitness losses were unexpectedly drastic when compared with the fitness losses experienced by other RNA viruses, such as bacteriophage 6, vesicular stomatitis virus, or foot-andmouth disease virus (FMDV) subjected to similar passage regimens (6, 17, 24). Only 4 out of 10 HIV-1 clones could produce viable progeny after 15 plaque-to-plaque transfers, and 3 of the 4 survivors displayed important decreases in fitness (78). Very little is known about the numbers and types of mutations which accompany fitness decreases of RNA viruses when they are subjected to sequential bottleneck passages. In the case of the animal picornavirus pathogen FMDV, debilitated clones showed some unusual genetic lesions (infrequent or absent in populations evolved without intervening bottlenecks; 24, 25). Such lesions included mutations that resulted in amino acid replacements at internal sites of the viral capsid and a unique elongation of five adenylate residues which resulted in an internal polyadenylate tract of variable length preceding the second functional AUG initiation codon of the FMDV genome (24, 25). No information on genetic lesions associated with fitness losses in retroviral genomes is available. Here we report complete HIV-1 genomic sequences of HIV-1 clones subjected to plaque transfers that led to severe fitness losses. The results reveal a broad spectrum of mutations associated with fitness decrease and an unexpected distribution of mutations along the HIV-1 genome. MATERIALS AND METHODS HIV-1 clones. The origin and passage history of the biological clones of HIV-1 used in the present study have been previously described (78). Briefly, virus clones were isolated by plating a natural isolate of HIV-1, termed S61, on MT-4 cells. Virus populations D1, G1, I1, and K1 are from randomly chosen, individual plaques. After the first plating, viruses from individual plaques (in the range of 9546

2 VOL. 74, 2000 MUTATIONS AND BOTTLENECKS IN HIV each passaged clone relative to the corresponding initial clone showed that transitions were 2.8-fold more frequent than transversions and that A G and G A accounted for 20% and 36%, respectively, of all mutation types; nonsynonymous mutations represented 49% of the total; an insertion of one nucleotide was present in clone I15 (Table 2). Mutation frequencies varied up to sevenfold among lineages (range, 4.4 TABLE 1. Synthetic oligonucleotide primers employed for nucleotide sequence determination of the HIV-1 genome a Nucleotide sequence FIG. 1. Scheme of passages of HIV-1 clones subjected to plaque-to-plaque transfers in MT-4 cells. Clonal populations (HIV-1 isolated from individual plaques) are depicted as filled squares. The experimental procedures and the origins of natural HIV-1 isolate S61 and clones B1 to K1 are given in reference 78 and in Materials and Methods. HIV-1 clones are indicated by letters followed by a number which gives the total number of plaque-to-plaque transfers undergone by the clone. Infectious virus could not be rescued from viral populations B15, E13, G7, H13, and J15 as described in reference to 10 5 PFU) were diluted in 300 l of culture medium and plated on fresh MT-4 cells, and this process was repeated a number of times (Fig. 1). Plaques appeared 7 to 10 days after infection. Fitness of the clonal populations of HIV-1 was determined by growth-competition experiments in MT-4 cells, and populations were analyzed by the heteroduplex tracking assay as previously described (78). DNA extraction, PCR amplification, and nucleotide sequencing. DNA was extracted using an Instagene purification matrix (Bio-Rad) according to the manufacturer s instructions. To determine the consensus nucleotide sequence of the entire HIV-1 genome in individual virus clones, a collection of overlapping sets of oligonucleotide primers was used. They either have been previously described (46, 47) or were designed for the present experiments (Table 1). HIV-1 DNA was amplified using nested PCR. The first amplifications (external primers) were carried out using the GeneAmp PCR kit (Perkin-Elmer) and resulted in the copying of 1,235-, 4,253-, and 6,686-bp fragments, comprising residues 1 through 1235, 546 through 4799, and 2975 through 9661, respectively; residue numbers correspond to those of the genome of HIV-1 isolate HXB2 (35). Internal amplifications yielded fragments of 500 to 1,500 residues, which were used for nucleotide sequence determination. For amplification of short regions of gag (positions 1337 to 1598) and env (positions 7071 to 7333), a single PCR amplification was carried out. Both external and internal amplifications involved 35 cycles with temperatures chosen according to the composition of the oligonucleotide primers (78). Before sequencing, the PCR mixture was digested with exonuclease I and shrimp alkaline phosphatase (Amersham Life Sciences). Nucleotide sequences were determined on the two cdna strands, with an ABI 373 automatic sequencer. Multiple sequence alignments were obtained using the CLUSTAL W program (71). The newly determined nucleotide sequences have been deposited in the EMBL sequence database with accession numbers AF256204, AF256205, AF256206, AF256207, AF256208, AF256209, AF256210, and AF RESULTS Mutation accumulation as a result of bottleneck transfers. HIV-1 clones underwent severe fitness losses as a result of serial plaque-to-plaque transfers in MT-4 cells (78). To determine the types and numbers of mutations accumulated during bottleneck transfers, the entire genomic nucleotide sequence of four HIV-1 clones (D1, G1, I1, and K1) and their derivatives after 15, 7, 15, and 15 plaque-to-plaque passages, respectively (termed D15, G7, I15, and K15, respectively [Fig. 1]), were obtained. The comparison of genomic nucleotide sequences of GCTTCAAGTAGTGTGTGCCCGTCTG (563, S) AGAGTCACACAACAGACGGG (582, A) TGACTAAAAGGGTCTGAGGG (614, A) CTCTGGTAACTAGAGATCCC (615, S) TCTCTAGCAGTGGCGCCCGAACAGGGAC (626, S) AGACAGGATCAGAAGAA (995, S) GGTGATATGGCCTGATGTACCATTTGCCCCTG (1204, A) CCAGGCCAGATGAGAGAACCAAGGG (1462, S) TGTCCAGAATGCTGGTAGGG (1642, A) CTCTCAGAAGCAGGAGCCG (2205, S) GTATTTAGTAGGACCTACACCT (2475, S) TCTTCTGTCAATGGCCATTGTTTAAC (2635, A) GGATTAGATATCAGTACAATGTGCTT (2971, S) CATGGATCCGATATCTAATCCCTGG (2991, A) GCTGGTGACCTTTCCATCC (3022, A) TAGATATCAGTACAATGTGCTTCCAC (2975, S) TATTGCTGGTGATCCTTTCC (3026, A) AAACATCAGAAAGAACCTCC (3207, S) GTTCATAACCCATCCAAAGG (3249, A) GCGGAATCTGTATGTCATTGACAGTCCAGCT (3300, A) CATGGAGTGTATTATGACCC (3492, S) CTTTCCCCATATTACTATGC (3704, A) AGTTTGTCAATACCCCTCCC (3793, S) AATCATTCAAGCACAACCAG (4061, S) TTAGATGGAATAGATAAGGC (4233, S) CTTGAAGCTTATCTATTCCATCTAAAAATAGT (4257, A) GGCGAATTCACTAGCCATTGCTCTCCA (4284, A) AGTGATTTTAACC (4299, S) GCTTCTATATATCCACTGGC (4486, A) AAGTATGCTGTTTCTTGCCC (4528, A) AAGGGGGGATTGGGGGGTACAGTGCAGGG (4792, S) TAGCCCTTCCAGTCCCCCCTTTTCTTTTA (4799, A) CTTTCCCCTGCACTGTACCC (4825, A) TACTAATCTAGCCTCCCCTAGTGGGATGTG (5235, A) GCCTCTGTGGCCCTTGGTCTTCTGGGG (5595, A) CAGAAAAGCTTGTCGACATAGCAGAATAGG (5576, S) TTAGGCATCTCCTATGGCAGGAAGAAGCGG (5957, S) CCCATAATAGACTGTGACCC (6347, A) TGTGGGTTGGGGTCTGTGGG (6469, A) ATGGGATCAAAGCCTAAAGCCATGTG (6557, S) AGGATACCTTTGGACAGGCC (6852, A) TCAGCACAGTACAATGTACACATGG (6949, S) ATAAGCTTGCAGTCTAGCAGAAGAAGA (7004, S) CAATCCTCAGGAGGGGAC (7311, S) TGCATCTCAATTTCTGGGCTCCCCTCCTGAG (7345, A) AGGAGTCCTCCCCTGGGTCTTAAGTA (7648, A) AGTGCTTCCTGCTGCTCCCAAGAACCCAAG (7811, A) TCTTGCCTGGAGCTGTTTGATGCCCCAGAC (7961, A) TTGGAATTGGATAAGTGGGC (8205, S) GTGAATAGAGTTAGGCAGGG (8337, S) GAAATGACAATGGTGAGTATCCCTGCC (8376, A) CGATTCCTTCGGGCCTGTCGGGTCCCC (8424, A) TGTGGAACTTCTGGGACGCAGGGGGTGGG (8567, S) CAAGGAGGAGGAGGAGGTGGGTTTTCC (8977, S) TGGAAGGGCTAATTTGGTCCCAGA (9086, S) CTGGGACCAAATTAGCCCTTCCAGTCC (9108, A) a Sequences are written from 5 to 3 ; data in parentheses are the position of the 5 nucleotide of each primer according to the genomic nucleotide numbering of isolate HXB2 (35) and primer orientation (S, sense [same orientation as genomic RNA]; A, antisense [complementary to genomic RNA]). Oligonucleotide primers were purchased from Isogen (Maarssen).

3 9548 YUSTE ET AL. J. VIROL. TABLE 2. Number and types of mutations in the genome of HIV-1 clones subjected to serial plaque transfers Clones compared a Fitness decrease (%) b Mutation frequency c No. of mutationsd A 3 C A 3 G C 3 A C 3 G C 3 T G 3 A G 3 T T 3 A T 3 C T 3 G Other Total D1, D G1, G7 ND I1, I K1, K Total a The entire genomic nucleotide sequence of the indicated clones was determined as described in Materials and Methods. b Fitness decrease refers to the comparison of D15, I15, and K15 with their corresponding initial clones D1, I1, and K1; it is expressed as percent reduction, calculated as described in reference 78. For G7 a relative fitness value could not be calculated because the virus yield was insufficient to perform competition passages (78). c Mutation frequency is the number of mutations found in the genome of D15, G7, I15, or K15 (when compared with the corresponding initial clones D1, G1, I1, or K1) divided by the total number of nucleotides sequenced (in this case, the entire HIV-1 genome, or 9.1 kb); therefore, values are expressed in substitutions per nucleotide. d Transversions A 3 T and G 3 C were not found in the genomes of the clones analyzed. Other, nsertion of one nucleotide at genomic residue 584 (according to the numbering for the genome of HXB2 [35]) in the leader sequence. The location of mutations in the HIV-1 genome is given in Fig. 2 and is discussed in the text to substitutions per nucleotide [Table 2]). There was no obvious correlation between fitness decrease and mutation types or frequencies; for example, clone G7, which was debilitated to the point of not allowing a reliable determination of fitness value (78), showed a mutation frequency that was sevenfold lower than that of I15 (Table 2). Unusual distribution of mutations. Mutation frequencies in env are generally higher than in gag and pol when natural HIV-1 isolates are compared (35, 44, 57, 58). In contrast, the HIV-1 clones debilitated by serial plaque transfers showed average mutation frequencies that were threefold higher for gag than env (Fig. 2). No mutations were found in tat, vpu, and rev. Most remarkable was the absence of mutations in the regions encoding variable loops of gp120, particularly the V3 loop. The asymmetric distribution of mutations was visualized by dividing the HIV-1 genome into three arbitrary regions of similar length: region 1, residues 1 through 3028; region 2, residues 3029 through 6065; and region 3, residues 6066 through Taking into account all mutations scored for clones D15, G7, I15, and K15 (as quantitated in Table 2), we found mutation frequencies for regions 1, 2, and 3 of , , and substitutions per nucleotide, respectively. The results suggest that plaque-to-plaque transfers of HIV-1 lead to accumulation of mutations at multiple sites of the HIV-1 genome, following a pattern which is quite different from that observed in the natural evolution of HIV-1 in infected hosts. Conservation of the V3 loop. The unusual distribution of mutations found in D15, G7, I15, and K15 and the absence of mutations in the region encoding the variable V3 loop of gp120 prompted us to extend nucleotide sequence determinations to additional HIV-1 clones subjected to serial bottleneck events. These additional analyses included two clones from each of the lineages D15, G7, and K15, one clone from I15, and clones from independent lineages which were previously described (78), including three clones from F15 and one clone from H13 (Fig. 1). The analysis involved nucleotide sequences of residues 7071 to 7333 (which include the V3-coding region) and residues 1337 to 1598 (within the p24-coding region). The comparison of nucleotide sequences with those of the corresponding initial clones fully confirmed the bias in the distribution of mutations; in all, 13 replacements were found in the gag region analyzed (which represents a mutation frequency of substitutions per nucleotide), while no replacements were found in the V3-coding region (mutation frequency, substitutions per nucleotide). The statistical significance of the biased distribution of mutations was evaluated by comparing the expected versus the actual number of mutations in gag, pol, and env for regions 1, 2, and 3 into which the genome was arbitrarily divided (Fig. 2), as well as for the short gag and env stretches for the additional clones from populations D15, F15, G7, H13, I15, and K15. These results (Table 3) indicate high statistical significance of the biased mutant distribution. The degree of statistical significance of the biased distribution did not vary when either all G A mutations or just G A mutations found in clone I15 were excluded from the calculations (in all cases, P [ 2 test]). Therefore, accumulation of mutations that were associated with serial bottleneck events and with fitness loss of HIV-1 affected genomic regions that are less variable during the natural evolution of the virus. DISCUSSION The results reported here describe the numbers and types of mutations associated with fitness loss of HIV-1 as a result of the operation of Muller s ratchet (Table 2; Fig. 2). For clones D15, G7, and K15, the average mutation frequency ( substitutions per nucleotide, measured relative to the genomic nucleotide sequence of their respective parental clones D1, G1, and K1) was 12 mutations per genome (range, 10 to 15), with a predominance of transitions (75% of all mutations) over transversions. These figures are similar to those of previous determinations of the number of mutations accompanying Muller s ratchet in the FMDV genome an average of six mutations per genome, with 77% of these transition mutations (24). However, clone I15 displayed a different pattern in that its mutation frequency corresponded to 28 mutations per genome with an overabundance of G A transitions (43% of all mutations [Table 1]). G A is one of the substitutions that have been associated with hypermutagenesis in HIV-1 (72, 73) and a number of other viruses (reviewed in 5, 43). In clone I15, G A transitions were distributed rather uniformly along the genome. Several possible mechanisms have been proposed to explain biased hypermutagenesis (5, 43), including alterations in intracellular deoxynucleotide pools. The sequence context of 67% of the G A transitions in clone I15 was GpA or GpG, which suggests a possible influence of low dctp levels during minus cdna synthesis in the origin of this mutation type (43). Our results with debilitated HIV-1 clones emphasize the stochastic nature of the G A mutation bias because it was observed in only one of four clones derived from the same viral isolate, and these clones were subjected to identical treat-

4 VOL. 74, 2000 MUTATIONS AND BOTTLENECKS IN HIV FIG. 2. Location of mutations found in HIV-1 clones D15, G7, I15, and K15, relative to their parental counterparts. The upper part indicates HIV-1 genes and regulatory regions based on the compilation of Korber et al. (35). The four horizontal bars in the center of the figure indicate the positions of mutations along the genome (9.1 kb) in the four clones analyzed (from top to bottom, D15, G7, I15, and K15 [described in Materials and Methods]); vertical lines within these bars indicate one, two, or three mutations, according to thickness. Mutations were found at positions 35, 171, 377, 379, 570, 584, 760, 807, 833, 988, 1128, 1161, 1188, 1351, 1467, 1545, 1578, 1596, 1810, 1863, 1875, 1937, 1961, 1966, 2145, 2174, 2329, 2668, 2804, 3068, 3114, 3129, 3945, 4458, 5239, 5270, 5342, 5422, 5684, 5686, 6588, 6655, 6670, 7962, 8095, 8890, 8900, and 8989 according to the numbering of HIV-1 isolate HXB2 (35). The gp120-coding region of env has been enlarged to depict the positions of variable loops V1 to V5; two mutations affected the V1-coding region. The two shaded rectangles correspond to genome positions 1337 to 1598 (gag [left shaded rectangle]) and 7071 to 7333 (env [right shaded rectangle]), which have been sequenced for a number of additional HIV-1 clones to confirm the asymmetric distribution of mutations (see text). The mutations found in these additional clones are not included in this scheme. The bottom part shows the three arbitrary regions into which the HIV-1 genome was divided to illustrate the bias in the distribution of mutations along the genome. Procedures used for nucleotide sequence determination are described in Materials and Methods, and the oligonucleotide primers are listed in Table 1. ment during the serial plaque transfers (Fig. 1). If the mechanism of nucleotide pool bias was in operation (43), it must have been triggered either by extremely subtle perturbations in the intracellular environment or by differences among the genomes of the four clones, differences that existed initially or that were generated in the course of passaging. In the latter case, the mutational biases must be subjected to indeterminations derived from the dynamics of mutant generation within the quasispecies swarms (reviewed in 10, 20). A dominance of G A transitions was also found in an analysis of mutations in a lacz -based reporter gene, which was constructed to study a single cycle of HIV-1 replication (39). However, there are important differences in the mutant repertoire found following a single cycle of replication and in our clones subjected to serial plaque transfers. In the former study, G A, C T, and T C mutations occurred at frequencies of , , and substitutions per nucleotide, respectively, while in our study these same mutations occurred at frequencies of , , and , respectively (Table 2). After a singlecycle replication, T G, T A, and A G each occurred at a frequency of substitutions per nucleotide, while in our clones the values for these substitutions ranged from to substitutions per nucleotide. In addition, A C, C A, C G, and G T mutations found in HIV-1 TABLE 3. Expected versus actual number of mutations in different genomic regions of HIV-1 clones subjected to serial plaque transfers Genomic regions compared No. of mutations (P f ) Expected Found gag, pol, env a 8 gag, 15.7 pol, 13.2 env b 19 gag, 10pol, 5env ( 0.001) R1, R2, R3 a,c 15.8 R1, 15.8 R2, 15.8 R3 b 30 R1, 11 R2, 8 R3 ( 0.001) gag ( ), env ( ) d 6.8 gag, 6.8 env e 13 gag, 0env ( 0.001) a Comparisons involve mutations found in clones D15, G7, I15, and K15 relative to their corresponding parental clones D1, G1, I1, and K1 (Table 2). b The expected numbers of mutations are based on the mutation frequencies given in Table 2, assuming a random distribution of mutations along the genome. c R1, R2, and R3 indicate genomic regions 1, 2, and 3, as depicted in Fig. 2. d Comparisons involve mutations at genomic residues 1337 through 1598 and 7071 through 7333 found in three clones from lineage F15, two clones each from lineages D15, G7, and K15, and one clone each from lineages H13 and I15, as described in the text and in Fig. 1. e The expected numbers of mutations are based on the average mutation frequencies for genomic residues 1337 through 1598 (gag) and 7071 through 7333 (env) assuming a random distribution of mutations along the two genomic stretches. f P values were calculated by the 2 test.

5 9550 YUSTE ET AL. J. VIROL. clones (Table 2) were not represented among the mutations found after a single infectious cycle (39). These variations in mutation types and frequencies probably arose not only from differences in the number of replication cycles but also from the sequence context in the template being copied in a different biological environment (43). The most unexpected finding in the analysis of low-fitness HIV-1 clones was the distribution of mutations along the genome (Fig. 2), with a statistically significant accumulation of mutations in gag and the first third of the genome, relative to env, which appears as the most conserved genomic region in all clones examined (Fig. 2; Table 3). This is in sharp contrast to results with natural HIV-1 isolates (35, 44, 57, 58) and with large-population passages of HIV-1 clones derived also from natural isolate S61 in cell culture (64); in all of these analyses, gag and pol showed more nucleotide and amino acid sequence conservation than env. Several mechanisms could contribute to this striking difference in the distribution of mutations. In the course of plaque-to-plaque transfers, fitness gains or purifying selection is probably diminished since competition among genomes from the quasispecies is limited to the period of plaque development (10, 25). In this view, the higher variation normally seen in env relative to gag and pol would be essentially due to selection for immune evasion, for adaptation to alternative cellular receptors, increased particle stability, etc. Evidence for selection in vivo has been obtained for HIV-1 and for simian immunodeficiency virus (2, 3, 26, 34, 48, 54, 62, 77). However, even if replicative optimization of the mutant spectrum was limited as a result of bottlenecking, the deficit in mutations in env remains to be explained. There are at least two possibilities (which are not mutually exclusive): env may have a lower tolerance for mutations than gag and the 5 third of the genome under the cell culture environment in which the passages were carried out, or HIV-1 genome replication may be more error prone in the process of copying gag than when copying env. Constraints to accept replacements in surface proteins were documented through functional and structural studies with FMDV (12 and references therein). The mutant repertoire in viral quasispecies could be strongly influenced by tolerance to nucleotide and amino acid substitutions, including silent replacements in coding regions (12, 38, 40, 67). In HIV-1, constraints in surface proteins could come about from the need always to use the cellular receptors presented by MT-4 cells in culture and to enter this same cell type monotonously in an invariant cell culture environment. Purifying selection during plaque growth, which must include many cycles of replication, may have contributed to the observed bias in the distribution of mutations along the genome. A possible molecular basis for a difference in accuracy during copying of different genome segments of HIV-1 is not obvious. The lowest number of mutations was seen in the genomic region copied immediately after the first strand transfer in the synthesis of minus-strand DNA by reverse transcriptase (RT) (reviewed in reference 68). Since processivity of RT is limited, it could be proposed that as synthesis proceeds inside the nucleocapsid, accuracy may decrease as a result of environmental alterations (ionic composition, deoxynucleoside triphosphate pools, etc. [43]). It has been suggested that misalignment mutagenesis could be more frequent during dissociation and reinitiation of RT-catalyzed reactions (reviewed in 1). However, examination of the sequence context of each mutation suggests that the frequency of mutations which may have occurred as a result of template misalignment (1, 53) is not significantly different for regions 1, 2, and 3, into which we have divided the HIV-1 genome (52, 64, and 63%, respectively). Other effects on fidelity or, more likely, a combination of TABLE 4. Amino acid replacements associated with nonsynonymous mutations during plaque-to-plaque transfers of HIV-1 Amino acid replacement a Acceptability b Frequency in database c HIV-1 protein and possible structural and functional significance d R15K 5 High p17 matrix S67A 5 High p17 matrix S209A 5 High p 24 capsid C-terminal dimerization domain K14R 5 Not found p7 nucleocapsid flanking first zinc finger motif F16L 4 Not found p7 nucleocapsid in first zinc finger motif I14S 2 High p6 E40G 4 Not found RT in an -helix in fingers subdomain V189I e 5 Not found RT in palm subdomain near active site E194K 4 Not found RT in palm subdomain near active site V466I 5 High RT in a -sheet of RNase H V77I 5 Not found Integrase, in catalytic D, D-35-E domain ( 2) P67T 4 High Vif K77R 5 High Vif T101N 4 Low Vif V128I 5 High Vif G43E 4 Low Vpr S144I 2 Not found gp160, in V1 loop in gp120 E148G 4 Not found gp160, in V1 loop in gp120 V580I 5 High gp160, in gp41 ectodomain D624G 4 Low gp160, in gp41 ectodomain A32T 5 Not found Nef R35Q 3 High Nef E65Stop f Nef E154K 5 Low Nef a Amino acids are numbered for each individual protein, according to the numbering for isolate HXB2 found in the data banks (35). b The degree of acceptability of the amino acid substitution is given according to reference 27; the acceptability scale is from 0 to 6, with the latter value representing replacement by the same amino acid. c The database consulted is the one presented in reference 35, and it was again retrieved on April 18, 2000, by entering GenBank and EMBL databases. d Location of amino acid replacements and their possible significance is based on current databases (35) and overviews on HIV-1 structure-function relationships (references 7, 9, 28, and 30 and references therein). e This replacement has been correlated with resistance to nonnucleoside RT inhibitors (references 11, 28, 33, 35, and 46 and references therein). f This mutation leads to an amber termination codon in Nef. factors outlined in previous paragraphs may converge to produce the unusual distribution of mutations seen in HIV-1 clones as a result of operation of Muller s ratchet. A total of 8 out of 20 nonsynonymous replacements found among the HIV-1 clones analyzed have not been recorded in current sequence data banks (35; Table 4). An attractive possibility is that replacements in gag could have multiple effects in RNA-protein interactions, nucleocapsid assembly, and protein stability (16, 30) and that such effects could contribute to fitness loss. It must also be considered that Vif, Vpr, and Nef are dispensable functions for HIV-1 replication in some permissive cell lines, including MT-4 (7, 49). Therefore, the accumulation of nonsynonymous replacements in vif, vpr, and nef genes (Fig. 2) could be of little consequence for plaque formation in MT-4 cells. However, an evaluation of the influence of amino acid replacements (individually or in combination) in viral fitness would require analysis of the effects of candidate mutations when introduced into infectious clones or examination of possible reversions and fixation of compensatory mutations upon fitness recovery of the debilitated HIV-1 clones. These studies are now in progress. In conclusion, some mutations associated with the operation

6 VOL. 74, 2000 MUTATIONS AND BOTTLENECKS IN HIV of Muller s ratchet in HIV-1 have not been previously reported among natural isolates evolved over more than two decades (35; Table 4). Furthermore, the mutations were distributed along the viral genome, unlike mutations in natural HIV-1 isolates, and env was the most conserved genomic region. An interesting possibility is that, in vivo, HIV-1 is not subjected to as severe bottleneck events as in experiments designed to accentuate Muller s ratchet. The observations reported here add to the complexities inherent in the relationships between occurrence of mutations and what can be eventually observed upon examination of genomic nucleotide sequences. The HIV- 1 mutational pattern could be made to vary with respect to hundreds of sequences recorded in data banks simply by changing the passage regimen, without intervening, externally applied, selective forces. ACKNOWLEDGMENTS Work at Centro de Biología Molecular Severo Ochoa was supported by grants FIS98/ and PM C02-01 and that at Centro Nacional de Biología Fundamental was supported by grants FIS00/0266 and FIS98/ E.Y. was supported by a postdoctoral fellowship from Comunidad Autónoma de Madrid. REFERENCES 1. Bebenek, K., and T. A. Kunkel The fidelity of retroviral reverse transcriptases, p In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Gold Spring Harbor, N.Y. 2. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. Oldstone, and G. M. Shaw Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3: Borrow, P., and G. M. Shaw Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol. Rev. 164: Carrillo, C., J. Plana, R. Mascarella, J. Bergada, and F. Sobrino Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology 179: Cattaneo, R., and M. A. Billeter Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176: Chao, L Fitness of RNA virus decreased by Muller s ratchet. Nature 348: Chen, I. S. Y., H. Koprowski, A. Srinivasan, and P. K. Vogt (ed.) Transacting functions of human retroviruses. Springer-Verlag KG, Berlin, Germany. 8. Coffin, J. M HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: Coffin, J. M., S. H. Hughes, and H. E. Varmus Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 10. Domingo, E., C. Biebricher, J. J. Holland, and M. Eigen Quasispecies and RNA virus evolution: principles and consequences. Landes Bioscience, Austin, Tex. 11. Domingo, E., C. Escarmís, L. Menéndez-Arias, and J. J. Holland Viral quasispecies and fitness variations, p In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, San Diego, Calif. 12. Domingo, E., M. G. Mateu, C. Escarmís, E. Martínez-Salas, D. Andreu, E. Giralt, N. Verdaguer, and I. Fita Molecular evolution of aphthoviruses. Virus Genes 11: Domingo, E., R. G. Webster, and J. J. Holland (ed.) Origin and evolution of viruses. Academic Press, San Diego, Calif. 14. Dougherty, J. P., and H. M. Temin Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 62: Drake, J. W Rates of spontaneous mutation among RNA viruses. Proc. Natl. Acad. Sci. USA 90: Druillennec, S., A. Caneparo, H. de Rocquigny, and B. P. Roques Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J. Biol. Chem. 274: Duarte, E., D. Clarke, A. Moya, E. Domingo, and J. Holland Rapid fitness losses in mammalian RNA virus clones due to Muller s ratchet. Proc. Natl. Acad. Sci. USA 89: Eigen, M Self-organization of matter and the evolution of biological macromolecules. Naturwissenschaften 58: Eigen, M On the nature of virus quasispecies. Trends Microbiol. 4: Eigen, M., and C. K. Biebricher Sequence space and quasispecies distribution, p In E. Domingo, P. Ahlquist, and J. J. Holland (ed.), RNA genetics, vol. 3. CRC Press, Inc., Boca Raton, Fla. 21. Eigen, M., J. McCaskill, and P. Schuster Molecular quasispecies. J. Phys. Chem. 92: Eigen, M., and P. Schuster The hypercycle: a principle of natural self-organization. Springer-Verlag KG, Berlin, Germany. 23. Elena, S. F., F. González-Candelas, I. S. Novella, E. A. Duarte, D. K. Clarke, E. Domingo, J. J. Holland, and A. Moya Evolution of fitness in experimental populations of vesicular stomatitis virus. Genetics 142: Escarmís, C., M. Dávila, N. Charpentier, A. Bracho, A. Moya, and E. Domingo Genetic lesions associated with Muller s ratchet in an RNA virus. J. Mol. Biol. 264: Escarmís, C., M. Dávila, and E. Domingo Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller s ratchet. J. Mol. Biol. 285: Evans, D. T., D. H. O Connor, P. Jing, J. L. Dzuris, J. Sidney, J. da Silva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, T. Vogel, C. D. Pauza, R. E. Bontrop, R. DeMars, A. Sette, A. L. Hughes, and D. I. Watkins Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5: Feng, D. F., M. S. Johnson, and R. F. Doolittle Aligning amino acid sequences: comparison of commonly used methods. J. Mol. Evol. 21: Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skalka Virology: molecular biology, pathogenesis, and control. ASM Press, Washington, D.C. 29. Forns, X., R. H. Purcell, and J. Bukh Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol. 7: Freed, E. O HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251: Goudsmit, J., A. de Ronde, E. de Rooij, and R. de Boer Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J. Virol. 71: Goulder, P., D. Price, M. Nowak, S. Rowland-Jones, R. Phillips, and A. McMichael Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol. Rev. 159: Havlir, D. V., S. Eastman, A. Gamst, and D. D. Richman Nevirapineresistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70: Kimata, J. T., L. Kuller, D. B. Anderson, P. Dailey, and J. Overbaugh Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5: Korber, B., C. Kuiken, B. Foley, B. Hahn, F. McCutchan, J. Mellors, and J. Sodroski Human retroviruses and AIDS: a compilation and analysis of nucleic acids and amino acid sequences. Theoretical Biology and Biophysics Group T-10. Los Alamos, N.M. 36. Kurosaki, M., N. Enomoto, T. Nouchi, I. Sakuma, F. Marumo, and C. Sato Fraction-specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia. J. Med. Virol. 46: Lech, W. J., G. Wang, Y. L. Yang, Y. Chee, K. Dorman, D. McCrae, L. C. Lazzeroni, J. W. Erickson, J. S. Sinsheimer, and A. H. Kaplan In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J. Virol. 70: Lobert, P. E., N. Escriou, J. Ruelle, and T. Michiels A coding RNA sequence acts as a replication signal in cardioviruses. Proc. Natl. Acad. Sci. USA 96: Mansky, L. M., and H. M. Temin Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69: McKnight, K. L., and S. M. Lemon Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J. Virol. 70: McMichael, A. J., and R. E. Phillips Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15: Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58: Meyerhans, A., and J.-P. Vartanian The fidelity of cellular and viral polymerases and its manipulation for hypermutagenesis, p In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, Inc., San Diego, Calif. 44. Montagnier, L Human immunodeficiency virus (Retroviridae). In A. Granoff and R. G. Webster (ed.), Encyclopedia of virology. Academic Press, Inc., San Diego, Calif.

7 9552 YUSTE ET AL. J. VIROL. 45. Muller, H. J The relation of recombination to mutational advance. Mutat. Res. 1: Nájera, I., A. Holguín, M. E. Quiñones-Mateu, M. A. Muñoz-Fernández, R. Nájera, C. López-Galíndez, and E. Domingo Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69: Nájera, I., D. D. Richman, I. Olivares, J. M. Rojas, M. A. Peinado, M. Perucho, R. Najera, and C. Lopez-Galindez Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res. Hum. Retrovir. 10: Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13: Nishino, Y., M. Kishi, M. Sumiya, K. Ogawa, A. Adachi, K. Maotani-Imai, S. Kato, K. Hirai, and K. Ikuta Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells. Arch. Virol. 120: Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. USA 92: Novella, I. S., C. L. Hershey, C. Escarmis, E. Domingo, and J. J. Holland Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J. Mol. Biol. 287: Novella, I. S., J. Quer, E. Domingo, and J. J. Holland Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J. Virol. 73: Pathak, V. K., and H. M. Temin Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66: Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: Preston, B. D., and J. P. Dougherty Mechanisms of retroviral mutation. Trends Microbiol. 4: Quiñones-Mateu, M. E., J. L. Albright, A. Mas, V. Soriano, and E. J. Arts Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. J. Virol. 72: Quiñones-Mateu, M. E., A. Holguín, J. Dopazo, I. Nájera, and E. Domingo Point mutant frequencies in the pol gene of human immunodeficiency virus type 1 are two- to three-fold lower than those of env. AIDS Res. Hum. Retrovir. 12: Quiñones-Mateu, M. E., A. Holguín, V. Soriano, and E. Domingo env gene diversity of HIV type 1 isolates from Spain. AIDS Res. Hum. Retrovir. 12: Ribeiro, R. M., S. Bonhoeffer, and M. A. Nowak The frequency of resistant mutant virus before antiviral therapy. AIDS 26: Robertson, D. L., B. H. Hahn, and P. M. Sharp Recombination in AIDS viruses. J. Mol. Evol. 40: Robertson, D. L., P. M. Sharp, F. E. McCutchan, and B. H. Hahn Recombination in HIV-1. Nature 374: Rodrigo, A. G., and J. I. Mullins Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res. Hum. Retrovir. 12: Sala, M., and S. Wain-Hobson Drift and conservation in RNA virus evolution: are they adapting or merely changing? p In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, Inc., San Diego, Calif. 64. Sánchez-Palomino, S., J. M. Rojas, M. A. Martínez, E. M. Fenyö, R. Nájera, E. Domingo, and C. López-Galíndez Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. J. Virol. 67: Schuitemaker, H., N. A. Kootstra, R. E. de Goede, F. de Wolf, F. Miedema, and M. Tersmette Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65: Schuster, P., and P. F. Stadler Nature and evolution of early replicons, p In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, Inc., San Diego, Calif. 67. Simmonds, P., and D. B. Smith Structural constraints on RNA virus evolution. J. Virol. 73: Telesnitsky, A., and S. P. Goff Strong-stop strand transfer during reverse transcription, p In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 69. Temin, H. M Is HIV unique or merely different? J. Acquir. Immune Defic. Syndr. 2: Temin, H. M The high rate of retrovirus variation results in rapid evolution, p In S. S. Morse (ed.), Emerging viruses. Oxford University Press, Oxford, United Kingdom. 71. Thompson, J. D., D. G. Higgins, and T. J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: Vartanian, J. P., A. Meyerhans, B. Asjo, and S. Wain-Hobson Selection, recombination, and G3A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65: Vartanian, J. P., A. Meyerhans, M. Sala, and S. Wain-Hobson G3A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dctp pool imbalance during reverse transcription. Proc. Natl. Acad. Sci. USA 91: Wain-Hobson, S Running the gamut of retroviral variation. Trends Microbiol. 4: Weaver, S. C., A. C. Brault, W. Kang, and J. J. Holland Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J. Virol. 73: Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92: Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272: Yuste, E., S. Sánchez-Palomino, C. Casado, E. Domingo, and C. López- Galíndez Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events. J. Virol. 73:

Drastic Fitness Loss in Human Immunodeficiency Virus Type 1 upon Serial Bottleneck Events

Drastic Fitness Loss in Human Immunodeficiency Virus Type 1 upon Serial Bottleneck Events JOURNAL OF VIROLOGY, Apr. 1999, p. 2745 2751 Vol. 73, No. 4 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Drastic Fitness Loss in Human Immunodeficiency

More information

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based

More information

Position: Professor of Research at the Spanish Research Council (CSIC).

Position: Professor of Research at the Spanish Research Council (CSIC). CURRICULUM VITAE OF ESTEBAN DOMINGO Birth date: Sept. 27, 1943, in Barcelona, Spain. Present address: Centro de Biología Molecular "Severo Ochoa" (CBMSO). Universidad Autónoma de Madrid. 28049-Cantoblanco,

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute

More information

Julianne Edwards. Retroviruses. Spring 2010

Julianne Edwards. Retroviruses. Spring 2010 Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus

More information

L I F E S C I E N C E S

L I F E S C I E N C E S 1a L I F E S C I E N C E S 5 -UUA AUA UUC GAA AGC UGC AUC GAA AAC UGU GAA UCA-3 5 -TTA ATA TTC GAA AGC TGC ATC GAA AAC TGT GAA TCA-3 3 -AAT TAT AAG CTT TCG ACG TAG CTT TTG ACA CTT AGT-5 OCTOBER 31, 2006

More information

The Swarm: Causes and consequences of HIV quasispecies diversity

The Swarm: Causes and consequences of HIV quasispecies diversity The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability

More information

Genetic Diversity in RNA Virus Quasispecies Is Controlled by Host-Virus Interactions

Genetic Diversity in RNA Virus Quasispecies Is Controlled by Host-Virus Interactions JOURNAL OF VIROLOGY, July 2001, p. 6566 6571 Vol. 75, No. 14 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.14.6566 6571.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Genetic

More information

HIV 101: Fundamentals of HIV Infection

HIV 101: Fundamentals of HIV Infection HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able

More information

Lecture 2: Virology. I. Background

Lecture 2: Virology. I. Background Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a

More information

HIV INFECTION: An Overview

HIV INFECTION: An Overview HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ

More information

Virus Genetic Diversity

Virus Genetic Diversity Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline

More information

*Department of Biology, Emory University, Atlanta, GA 30322; and Department of Biology, University of Oregon, Eugene, OR 97403

*Department of Biology, Emory University, Atlanta, GA 30322; and Department of Biology, University of Oregon, Eugene, OR 97403 Proc. Natl. Acad. Sci. USA Vol. 96, pp. 5095 5100, April 1999 Evolution Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens (disease evolution quasispecies RNA virus Muller

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease

More information

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia 1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia

More information

III. What are the requirements for taking and passing this course?

III. What are the requirements for taking and passing this course? 1 Molecular Virology Lecture # 1: Course Introduction I. Instructor and Background Dr. Richard Kuhn rjkuhn@bragg.bio.purdue.edu B-129 Lilly Hall 494-1164 Office Hours - Wednesday 10:30-11:30 II. Objective:

More information

Gkikas Magiorkinis, 1 Dimitrios Paraskevis, 1 Anne-Mieke Vandamme, 2 Emmanouil Magiorkinis, 1 Vana Sypsa 1 and Angelos Hatzakis 1 INTRODUCTION

Gkikas Magiorkinis, 1 Dimitrios Paraskevis, 1 Anne-Mieke Vandamme, 2 Emmanouil Magiorkinis, 1 Vana Sypsa 1 and Angelos Hatzakis 1 INTRODUCTION Journal of General Virology (2003), 84, 2715 2722 DOI 10.1099/vir.0.19180-0 In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation

More information

Lentiviruses: HIV-1 Pathogenesis

Lentiviruses: HIV-1 Pathogenesis Lentiviruses: HIV-1 Pathogenesis Human Immunodeficiency Virus, HIV, computer graphic by Russell Kightley Tsafi Pe ery, Ph.D. Departments of Medicine and Biochemistry & Molecular Biology NJMS, UMDNJ. e-mail:

More information

MedChem 401~ Retroviridae. Retroviridae

MedChem 401~ Retroviridae. Retroviridae MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The

More information

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase. Retroviruses ---The name retrovirus comes from the enzyme, reverse transcriptase. ---Reverse transcriptase (RT) converts the RNA genome present in the virus particle into DNA. ---RT discovered in 1970.

More information

HIV & AIDS: Overview

HIV & AIDS: Overview HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What

More information

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

HIV and drug resistance Simon Collins UK-CAB 1 May 2009 HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk Tip of the iceberg = HIV result, CD4, VL Introduction: resistance

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES 1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.

More information

7.014 Problem Set 7 Solutions

7.014 Problem Set 7 Solutions MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable

More information

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock

More information

Immunological transitions in response to antigenic mutation during viral infection

Immunological transitions in response to antigenic mutation during viral infection International Immunology, Vol. 12, No. 10, pp. 1371 1380 2000 The Japanese Society for Immunology Immunological transitions in response to antigenic mutation during viral infection L. M. Wahl 2, B. Bittner

More information

Originally published as:

Originally published as: Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell October 26, 2006 Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell 1. Secretory pathway a. Formation of coated vesicles b. SNAREs and vesicle targeting 2. Membrane fusion a. SNAREs

More information

number Done by Corrected by Doctor Ashraf

number Done by Corrected by Doctor Ashraf number 4 Done by Nedaa Bani Ata Corrected by Rama Nada Doctor Ashraf Genome replication and gene expression Remember the steps of viral replication from the last lecture: Attachment, Adsorption, Penetration,

More information

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also 6/1/2011 Biology of HIV Biology of HIV HIV belongs to a class of viruses known as retroviruses. Retroviruses are viruses that contain RNA (ribonucleic acid) as their genetic material. After infecting a

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

7.012 Quiz 3 Answers

7.012 Quiz 3 Answers MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84

More information

Viral Genetics. BIT 220 Chapter 16

Viral Genetics. BIT 220 Chapter 16 Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse

More information

Received 25 April 2002/Accepted 21 May 2002

Received 25 April 2002/Accepted 21 May 2002 JOURNAL OF VIROLOGY, Sept. 2002, p. 8757 8768 Vol. 76, No. 17 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.17.8757 8768.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Clustering

More information

Introduction to the Impact of Resistance in Hepatitis C

Introduction to the Impact of Resistance in Hepatitis C Introduction to the Impact of Resistance in Hepatitis C Sponsored by AbbVie 2/1/2017 Presented by Sammy Saab, MD, MPH, FACG, AGAF, FAASLD February 1 st, 2017 1 AbbVie disclosures This is an Abbvie sponsored

More information

Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness

Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness CLINICAL MICROBIOLOGY REVIEWS, Oct. 2007, p. 550 578 Vol. 20, No. 4 0893-8512/07/$08.00 0 doi:10.1128/cmr.00017-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Clinical Significance

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against

More information

Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies

Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies Jack da Silva North Carolina Supercomputing Center, MCNC, Research Triangle Park, NC; jdasilva@ncsc.org Austin Hughes Department

More information

Received 4 August 2005/Accepted 7 December 2005

Received 4 August 2005/Accepted 7 December 2005 JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination

More information

Chapter 6- An Introduction to Viruses*

Chapter 6- An Introduction to Viruses* Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses

More information

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds Uncatalyzed half-life Peptide hydrolysis uncatalyzed half-life = ~450 years IV protease-catalyzed half-life = ~3 seconds Life Sciences 1a Lecture Slides Set 9 Fall 2006-2007 Prof. David R. Liu In the absence

More information

Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics Coronaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Spherical enveloped particles studded with clubbed spikes Diameter 120-160 nm Coiled helical

More information

Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies

Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies Journal of General Virology (2000), 81, 85 95. Printed in Great Britain... Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies

More information

Overview: Chapter 19 Viruses: A Borrowed Life

Overview: Chapter 19 Viruses: A Borrowed Life Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between

More information

Introduction retroposon

Introduction retroposon 17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element

More information

HIV-1 Dual Infection and Neurocognitive Impairment

HIV-1 Dual Infection and Neurocognitive Impairment HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral

More information

numbe r Done by Corrected by Doctor

numbe r Done by Corrected by Doctor numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic

More information

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through

More information

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials

More information

Characterizing intra-host influenza virus populations to predict emergence

Characterizing intra-host influenza virus populations to predict emergence Characterizing intra-host influenza virus populations to predict emergence June 12, 2012 Forum on Microbial Threats Washington, DC Elodie Ghedin Center for Vaccine Research Dept. Computational & Systems

More information

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm. SECTION 25-1 REVIEW STRUCTURE VOCABULARY REVIEW Define the following terms. 1. virus 2. capsid 3. retrovirus 4. viroid 5. prion MULTIPLE CHOICE Write the correct letter in the blank. 1. The diameter of

More information

Fig. 1: Schematic diagram of basic structure of HIV

Fig. 1: Schematic diagram of basic structure of HIV UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR HIV & AIDS: An Overview What is HIV?

More information

How HIV Causes Disease Prof. Bruce D. Walker

How HIV Causes Disease Prof. Bruce D. Walker How HIV Causes Disease Howard Hughes Medical Institute Massachusetts General Hospital Harvard Medical School 1 The global AIDS crisis 60 million infections 20 million deaths 2 3 The screen versions of

More information

cure research HIV & AIDS

cure research HIV & AIDS Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may

More information

DATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.

DATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter

More information

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION 1. Feedback a. Negative feedback mechanisms maintain dynamic homeostasis for a particular condition (variable) by regulating physiological processes,

More information

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1 Journal of Cell and Tissue Research Vol. 10(3) 2359-2364 (2010) ISSN: 0973-0028 (Available online at www.tcrjournals.com) Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN

More information

Viruses Tomasz Kordula, Ph.D.

Viruses Tomasz Kordula, Ph.D. Viruses Tomasz Kordula, Ph.D. Resources: Alberts et al., Molecular Biology of the Cell, pp. 295, 1330, 1431 1433; Lehninger CD Movie A0002201. Learning Objectives: 1. Understand parasitic life cycle of

More information

HIV Life Cycle & Genetics

HIV Life Cycle & Genetics HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in

More information

The frequency of resistant mutant virus before antiviral therapy

The frequency of resistant mutant virus before antiviral therapy The frequenc of resistant mutant virus before antiviral therap Ru M. Ribeiro, Sebastian Bonhoeffer* and Martin A. Nowak Objective: To calculate the expected prevalence of resistant HIV mutants before antiviral

More information

CDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm

More information

Human Genome Complexity, Viruses & Genetic Variability

Human Genome Complexity, Viruses & Genetic Variability Human Genome Complexity, Viruses & Genetic Variability (Learning Objectives) Learn the types of DNA sequences present in the Human Genome other than genes coding for functional proteins. Review what you

More information

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2013 September 01.

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2013 September 01. NIH Public Access Author Manuscript Published in final edited form as: J Acquir Immune Defic Syndr. 2012 September 1; 61(1): 19 22. doi:10.1097/qai.0b013e318264460f. Evaluation of HIV-1 Ambiguous Nucleotide

More information

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity

High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure

More information

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors VIROLOGY Engineering Viral Genomes: Retrovirus Vectors Viral vectors Retrovirus replicative cycle Most mammalian retroviruses use trna PRO, trna Lys3, trna Lys1,2 The partially unfolded trna is annealed

More information

Under the Radar Screen: How Bugs Trick Our Immune Defenses

Under the Radar Screen: How Bugs Trick Our Immune Defenses Under the Radar Screen: How Bugs Trick Our Immune Defenses Session 7: Cytokines Marie-Eve Paquet and Gijsbert Grotenbreg Whitehead Institute for Biomedical Research HHV-8 Discovered in the 1980 s at the

More information

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T

More information

Section 6. Junaid Malek, M.D.

Section 6. Junaid Malek, M.D. Section 6 Junaid Malek, M.D. The Golgi and gp160 gp160 transported from ER to the Golgi in coated vesicles These coated vesicles fuse to the cis portion of the Golgi and deposit their cargo in the cisternae

More information

Hepadnaviruses: Variations on the Retrovirus Theme

Hepadnaviruses: Variations on the Retrovirus Theme WBV21 6/27/03 11:34 PM Page 377 Hepadnaviruses: Variations on the Retrovirus Theme 21 CHAPTER The virion and the viral genome The viral replication cycle The pathogenesis of hepatitis B virus A plant hepadnavirus

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

Lecture 11. Immunology and disease: parasite antigenic diversity

Lecture 11. Immunology and disease: parasite antigenic diversity Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html

More information

Grade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period

Grade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period The History of Vaccines Lesson Plan: Viruses and Evolution Overview and Purpose: The purpose of this lesson is to prepare students for exploring the biological basis of vaccines. Students will explore

More information

For all of the following, you will have to use this website to determine the answers:

For all of the following, you will have to use this website to determine the answers: For all of the following, you will have to use this website to determine the answers: http://blast.ncbi.nlm.nih.gov/blast.cgi We are going to be using the programs under this heading: Answer the following

More information

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

VIRUSES. 1. Describe the structure of a virus by completing the following chart. AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope

More information

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why?

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why? Life Sciences 1a Practice Problems 8 1. You have two strains of HIV one is a wild type strain of HIV and the second has acquired a mutation in the gene encoding the protease. This mutation has a dual effect

More information

Hepatitis B Virus infection: virology

Hepatitis B Virus infection: virology Hepatitis B Virus infection: virology 167 Falk Symposium: Liver under constant attack from fat to viruses III Falk Gastro-Konferenz 17.-21. September 2008 Congress Centrum Mainz Maura Dandri Department

More information

Spectrum of VP1 region genetic variants in the foot-and-mouth disease virus serotype O populations derived from infected cattle tongue epithelium

Spectrum of VP1 region genetic variants in the foot-and-mouth disease virus serotype O populations derived from infected cattle tongue epithelium Acta virologica 59: 305 310, 2015 doi:10.4149/av_2015_03_305 Spectrum of VP1 region genetic variants in the foot-and-mouth disease virus serotype O populations derived from infected cattle tongue epithelium

More information

Sequence Analysis of Human Immunodeficiency Virus Type 1

Sequence Analysis of Human Immunodeficiency Virus Type 1 Sequence Analysis of Human Immunodeficiency Virus Type 1 Stephanie Lucas 1,2 Mentor: Panayiotis V. Benos 1,3 With help from: David L. Corcoran 4 1 Bioengineering and Bioinformatics Summer Institute, Department

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length

More information

Rajesh Kannangai Phone: ; Fax: ; *Corresponding author

Rajesh Kannangai   Phone: ; Fax: ; *Corresponding author Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal

More information

Rama Nada. - Malik

Rama Nada. - Malik - 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect

More information

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection

Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection Eur. J. Immunol. 2001. 31: 3207 3217 CTL escape in nonpathogenic SIV infection 3207 Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection Amitinder

More information

7.013 Spring 2005 Problem Set 7

7.013 Spring 2005 Problem Set 7 MI Department of Biology 7.013: Introductory Biology - Spring 2005 Instructors: Professor Hazel Sive, Professor yler Jacks, Dr. Claudette Gardel 7.013 Spring 2005 Problem Set 7 FRIDAY May 6th, 2005 Question

More information

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants Journal of General Virology (2002), 83, 93 101. Printed in Great Britain... In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Clinical utility of NGS for the detection of HIV and HCV resistance

Clinical utility of NGS for the detection of HIV and HCV resistance 18 th Annual Resistance and Antiviral Therapy Meeting v Professor Janke Schinkel Academic Medical Centre, Amsterdam, The Netherlands Thursday 18 September 2014, Royal College of Physicians, London Clinical

More information

AP Biology Reading Guide. Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat

AP Biology Reading Guide. Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat AP Biology Reading Guide Name Chapter 19: Viruses Overview Experimental work with viruses has provided important evidence that genes are made of nucleic acids. Viruses were also important in working out

More information

Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution In Vivo

Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution In Vivo JOURNAL OF VIROLOGY, Mar. 1997, p. 2555 2561 Vol. 71, No. 3 0022-538X/97/$04.00 0 Copyright 1997, American Society for Microbiology Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution

More information

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC

More information

Reverse transcription and integration

Reverse transcription and integration Reverse transcription and integration Lecture 9 Biology 3310/4310 Virology Spring 2018 One can t believe impossible things, said Alice. I dare say you haven t had much practice, said the Queen. Why, sometimes

More information

Diagnostic Methods of HBV and HDV infections

Diagnostic Methods of HBV and HDV infections Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection

More information

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007 HIV Immunopathogenesis Modeling the Immune System May 2, 2007 Question 1 : Explain how HIV infects the host Zafer Iscan Yuanjian Wang Zufferey Abhishek Garg How does HIV infect the host? HIV infection

More information

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v Principles of Virology Department of Molecular Genetics & Microbiology Univ ersity of Florida, Gainesv ille, FL 1 Outline Virus cultivation Assay of viruses Virus genetics 2 Virus isolation Evidence of

More information

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter Prevention of infection 2 : immunisation How infection influences the host : viruses Peter Balfe, p.balfe@bham.ac.uk @pbalfeuk Let s have some LO s just for fun 1. Define the Immune response to viruses,

More information